Product Recalls in Texas

Product recalls affecting Texas — including food, drugs, consumer products, medical devices, and vehicles distributed to Texas. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,905 recalls have been distributed to Texas in the last 12 months.

55,713 total recalls
2,905 in last 12 months

Showing 24412460 of 13,609 recalls

DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Erythromycin Ophthalmic Ointment USP Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Betaxolol Ophthalmic Solution Recalled by Akorn, Inc. Due to CGMP Deviations:

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Olopatadine HCL Ophthalmic Solution Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Proparacaine Hydrochloride Ophthalmic Solution Recalled by Akorn, Inc. Due...

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Neomycin and Polymyxin B Sulfates Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: PAREMYD (hydroxyamphetamine hydrobromide/ tropicamide ophthalmic solution)...

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: AK-POLY-BAC brand of Bacitracin cand Polymixin B Sulfate Ophthalmic Ointment...

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: ERYTHROMYCIN OPHTHALMIC OINTMENT USP 0.5% Recalled by Akorn, Inc. Due to...

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Timolol Maleate Ophthalmic Solution Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Cromolyn Sodium Ophthalmic Solution Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Olopatadine HCl Ophthalmic Solution Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Artificial Tears OINTMENT Recalled by Akorn, Inc. Due to CGMP Deviations:

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Artificial Tears Solution Recalled by Akorn, Inc. Due to CGMP Deviations:

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Ciprofloxacin Ophthalmic Solution Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Moxifloxacin Ophthalmic Solution Recalled by Akorn, Inc. Due to CGMP Deviations:

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Olopatadine HCl Ophthalmic Solution Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Proparacaine Hydrochloride Ophthalmic Solution Recalled by Akorn, Inc. Due...

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 11, 2022· Fresenius Medical Care Holdings, Inc.

Recalled Item: 0.9% Sodium Chloride Injection Recalled by Fresenius Medical Care Holdings,...

The Issue: Lack of Assurance of Sterility: Leakage of 0.9% Sodium Chloride for...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 11, 2022· LNK International, Inc.

Recalled Item: NDC 0363-6171-09 Walgreens Sinus Pressure Recalled by LNK International,...

The Issue: Boxes mislabeled to read "Decongestant Free", but the product contains...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugOctober 7, 2022· Viatris Inc

Recalled Item: Octreotide Acetate Injection 500 mcg/mL Recalled by Viatris Inc Due to...

The Issue: Presence of Particulate Matter: Product complaint for the presence of glass...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund